| ABPP | Aβ binding peptide probe |
| AD | Alzheimer’s disease |
| Ahx | 6-aminohexanoic acid |
| Aβ42 | amyloid-beta 42 |
| BB2R | bombesin receptor 2 |
| BB3 | bombesin receptor 3 |
| BCa | breast cancer |
| BMG-1 | cerebral glioma cell line |
| CADD | computer-aided drug design |
| CCK | cholecystokinin receptors |
| CCK-2R | cholecystokinin receptor subtype 2 |
| CCP | positively charged octamer |
| cDNA | complementary DNA |
| CP04 | minigastrin analog DOTA-(dGlu)-6-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
| CSF | cerebral-cerebrospinal fluid |
| C-X-C | chemokine receptors |
| CXCR4 | chemokine receptor 4 |
| DBCO | dibenzocyclooctyne |
| DCIBzL | ((1-carboxy-5-(4-iodobenzamido)pentyl)carbamoyl)glutamic acid |
| DOTA | 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid |
| DOTATOC | 1,4,7,10-tetraazacyclododecan-4,7,10-tricarboxy-meth-1-yl-acetyl-d-Phe-Tyr3-octreotide |
| DTPA | pentetic acid, diethylenetriaminepentaacetic acid |
| EAT | Xenografted Ehrlich Ascites |
| ELISA | enzyme-linked immunosorbent assay |
| ESCC | esophageal squamous cell carcinoma |
| Fmoc | fluorenylmethoxycarbonyl protecting group |
| GCP II | glutamate carboxypeptidase II |
| GGT | gamma glutamyl transferase |
| GRPR | gastrin releasing peptide receptor |
| GSH | glutathione |
| HBED-CC | N,N′-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N-diacetic acid |
| HIV-1 | human immunodeficiency virus |
| MD | molecular dynamics |
| MMPs | matrix metalloproteases |
| MOLCAD | Computer-Aided Visualization and Manipulation of Models |
| MTC | medullary thyroid carcinoma cells |
| NOTA | 2,2′,2″-(1,4,7-triazacyclononane-1,4,7-triyl)triacetic acid |
| NOTA-CP01 | cyclo[Phe-Tyr-Lys-(iPr)-d-Arg-2-Nal-Gly-d-Glu]-Lys-(iPr)-butane-1,4-diamine-bis-t-butyl NOTA-NH2 |
| PCa | prostate cancer |
| PEG | polyethylene glycol |
| PET | positron emission tomography |
| PSMA | prostate-specific membrane antigen |
| RM2 | gastrin-releasing peptide receptor antagonist |
| S1 | non-prime section |
| S1′ | prime section |
| SAAC | single amino acid chelated |
| SAR | structure–activity relationship |
| SDF-1/CXCL12 | stromal cell-derived factor 1 |
| Siglec-9 | sialic acid-binding Ig-like lectin 9 |
| SPECT | single-photon emission computed tomography |
| SSTR2 | somatostatin receptor subtype 2 |
| TE1K1P−PEG4−DBCO−Y3-TATE | |
| TRNT | targeted radionuclide therapy |
| VAP-1 | vascular adhesion protein-1 |
| Y3-TATE | tyrosine 3-octreotate |